ImCheck Therapeutics
Developing immunotherapeutic antibodies targeting butyrophilins
- B2B
- Has physical offices
- Venture-backed
About ImCheck Therapeutics
Designs and develops novel immunotherapeutic antibodies targeting butyrophilins, with potential to enhance immune response and treat autoimmune diseases effectively
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- Marseille, La Libertad, Peru
- Founded
- 2015
- Revenue
- $2.6M – $20.7MTamtam estimate
- Website
- imchecktherapeutics.com
ImCheck Therapeutics at a glance
ImCheck Therapeutics is a B2B company in the Biotechnology industry, headquartered in Marseille, La Libertad, Peru.
ImCheck Therapeutics was founded in 2015.
ImCheck Therapeutics has 11–50 employees.
ImCheck Therapeutics's revenue is $2.6M – $20.7M (Tamtam estimate).
Selling to companies like ImCheck Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies